Share

October 2021; 11 (5) Case

Familial Cerebral Cavernous Malformation Mimicking Cerebral Amyloid Angiopathy

Mohamed Ridha, Yasmin Aziz, Joseph Broderick
First published January 25, 2021, DOI: https://doi.org/10.1212/CPJ.0000000000001055
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
129

Share

Article Information

vol. 11 no. 5 e796-e797
DOI: 
https://doi.org/10.1212/CPJ.0000000000001055
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received October 2, 2020
  • Accepted December 14, 2020
  • First Published January 25, 2021.

Article Versions

Copyright & Usage: 
© 2021 American Academy of Neurology

Author Disclosures

    1. Mohamed Ridha, MD*,
    2. Yasmin Aziz, MD* and
    3. Joseph Broderick, MD
  1. Mohamed Ridha, MD*,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Yasmin Aziz, MD* and
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Joseph Broderick, MD
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Travel expenses reimbursed by Universities as part as invited Visiting Professor over past 2 years - approximately 2-3 times per year. Honoraria for speaking placed in faculty academic fund within department.

    Editorial Boards:

    1. NONE

    Patents:

    1. Method for Controlling the Lysis of Coagulated Blood with Apolipoprotein e4 Phenotype. US Patent 7, 135, 305, issued November 15, 2006. Also, a closely related patent in 2007.

    Publishing Royalties:

    1. Elsevier as co-editor of Book

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Monies to Department of Neurology and Rehabilitation Medicine for my role as consultant for Ono Pharmaceuticals.

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Monies paid to Department of Neurology by Genentech for role on PRISMS Trial and TIMELESS Trial steering committee

    Research Support, Government Entities:

    1. PI for NINDS-funded National Coordinating Center for NIH StrokeNet 2013 to present. Co-investigator (Previous PI) of NINDS-funded Genetic and Environmental Risk Factors for Hemorrhagic Stroke NIH-NINDS R01 NS36695 1998- present, Co-investigator (Previous PI) NINDS- funded “Comparison of Hemorrhagic and Ischemic Strokes Among Blacks and Whites"NIH-NINDS R01 NS30678 1992-present. Multiple PI for NINDS funded MOST Trial. PI for NINDS funded FASTEST Trial. Co-investigator NIHLBI R01 HL134815 Saulius Sumanas (PI) CHMC. 5/15/2017 04/30/2021. NIH/NHLBI. The role of Collagen COL22A1 in intracranial Aneurysms & Vascular Stability.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Department of Neurology, University of Cincinnati, OH.
  1. Correspondence
    Dr. Ridha mridha{at}neomed.edu
View Full Text

Article usage

Article usage: January 2021 to February 2023

AbstractFullPdfSource
Jan 20214605Highwire
Feb 20218002Highwire
Mar 20215403Highwire
Apr 20211902Highwire
May 20212103Highwire
Jun 20212503Highwire
Jul 20212202Highwire
Aug 20212701Highwire
Sep 20211402Highwire
Oct 20211242017Highwire
Nov 20217095Highwire
Dec 202123465Highwire
Jan 20228537Highwire
Feb 20226313Highwire
Mar 20225946Highwire
Apr 20227252Highwire
May 20226112Highwire
Jun 20225408Highwire
Jul 20226814Highwire
Aug 202253110Highwire
Sep 20226827Highwire
Oct 202269113Highwire
Nov 202211506Highwire
Dec 20229584Highwire
Jan 20237013Highwire
Feb 20236134Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me